The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo

Clinical trial NCT00758862 · COMPLETED

Trial details

NCT number: NCT00758862
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Secondarily Infected Traumatic Lesions (SITL)Impetigo

Start date: 2008-12-01
Primary completion: 2009-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.